36.68

2.39% -0.90

After Hours: 36.66 -0.02 -0.05%

Liquidia Corp (LQDA)

Overview News Price History Option Chain Financials Discussions Forecast

Liquidia Corp stock is traded at $36.68, with a volume of 1.55M. It is down -2.39% in the last 24 hours and down -3.98% over the past month. Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Previous Close:

$37.58

Open:

$37.5

24h Volume:

1.55M

Relative Volume:

0.87

Market Cap:

$3.19B

Revenue:

$19.32M

Net Income/Loss:

$-141.47M

P/E Ratio:

-21.77

EPS:

-1.6851

Net Cash Flow:

$-120.48M

1W Performance:

+1.80%

1M Performance:

-3.98%

6M Performance:

+41.13%

1Y Performance:

+161.44%

1-Day Range:

$35.84

$38.66

1-Week Range:

$34.92

$39.61

52-Week Range:

$11.26

$46.67

Liquidia Corp Stock (LQDA) Company Profile

Name

Liquidia Corp

Sector

Healthcare (1116)

Industry

Drug Manufacturers - Specialty & Generic (82)

Phone

919.328.4400

Address

419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC

Employee

170

Twitter

@Liquidia_Inc

Next Earnings Date

2026-03-05

Latest SEC Filings

LQDA's Discussions on Twitter

Compare LQDA vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LQDA Liquidia Corp	36.68	3.27B	19.32M	-141.47M	-120.48M	-1.6851
TAK Takeda Pharmaceutical Co Adr	17.77	56.14B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	115.62	48.74B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.03	44.85B	14.54B	2.22B	2.58B	0.4879
TEVA Teva Pharmaceutical Industries Ltd Adr	28.57	34.12B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	536.12	23.35B	3.13B	1.27B	1.12B	26.39

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Initiated	Wells Fargo	Overweight
Aug-15-25	Resumed	Jefferies	Buy
May-19-25	Downgrade	Oppenheimer	Perform → Underperform
Dec-20-24	Initiated	Wells Fargo	Overweight
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-19-24	Upgrade	Raymond James	Outperform → Strong Buy
Aug-16-24	Initiated	Raymond James	Outperform
Jun-25-24	Initiated	Oppenheimer	Perform
Jan-05-24	Reiterated	Needham	Buy
Sep-19-22	Resumed	Wedbush	Underperform
Sep-01-22	Downgrade	Wedbush	Neutral → Underperform
Jul-22-22	Initiated	Ladenburg Thalmann	Buy
May-31-22	Initiated	BTIG Research	Buy
May-26-22	Initiated	BofA Securities	Buy
Dec-04-20	Initiated	H.C. Wainwright	Buy
Nov-20-20	Downgrade	Wedbush	Outperform → Neutral
Nov-08-18	Resumed	Jefferies	Buy
Sep-05-18	Initiated	Wedbush	Outperform
Aug-20-18	Initiated	Jefferies	Buy
Aug-20-18	Initiated	Needham	Buy

View All

Liquidia Corp Stock (LQDA) Latest News

Mar 12, 2026

Oppenheimer Forecasts Strong Price Appreciation for Liquidia (NASDAQ:LQDA) Stock - MarketBeat

Mar 12, 2026

Oppenheimer Raises Price Target for LQDA While Maintaining 'Unde - GuruFocus

Mar 12, 2026

Assessing Liquidia (LQDA) Valuation After Strong Earnings And YUTREPIA Driven Momentum - simplywall.st

Mar 12, 2026

Mar 11, 2026

Liquidia Corp (NASDAQ:LQDA) Shows High-Growth Momentum and Minervini Trend Alignment - ChartMill

Mar 11, 2026

Mar 10, 2026

Liquidia stock gains premarket on Q4 revenue beat – investors are betting on YUTREPIA growth - MSN

Mar 08, 2026

Liquidia Corporation (NASDAQ:LQDA) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 08, 2026

Liquidia (LQDA) Is Up 16.2% After Strong Q4 Profit and YUTREPIA-Fueled Revenue SurgeWhat's Changed - simplywall.st

Mar 08, 2026

Mar 07, 2026

Liquidia Balances Early YUTREPIA Profitability With L606 Development Push - simplywall.st

Mar 07, 2026

Liquidia (NASDAQ:LQDA) Upgraded at Wall Street Zen - MarketBeat

Mar 07, 2026

Mar 06, 2026

A Look At Liquidia (LQDA) Valuation After YUTREPIA Powered Revenue Growth And Profitability Shift - Yahoo Finance

Mar 06, 2026

Liquidia Analysts Boost Their Forecasts After Q4 Earnings - Benzinga

Mar 06, 2026

Liquidia (NASDAQ:LQDA) Stock Price Up 7% on Analyst Upgrade - MarketBeat

Mar 06, 2026

Liquidia (LQDA) Shares Surge Over 7% Amid Market Optimism - GuruFocus

Mar 06, 2026

Liquidia (LQDA) Sees Analyst Rating Surpass Expectations | LQDA Stock News - GuruFocus

Mar 06, 2026

Liquidia (NASDAQ:LQDA) Given New $44.00 Price Target at Wells Fargo & Company - MarketBeat

Mar 06, 2026

Needham & Company LLC Issues Positive Forecast for Liquidia (NASDAQ:LQDA) Stock Price - MarketBeat

Mar 06, 2026

HC Wainwright Forecasts Strong Price Appreciation for Liquidia (NASDAQ:LQDA) Stock - MarketBeat

Mar 06, 2026

Liquidia (LQDA) Sees Raised Price Target by HC Wainwright & Co. - GuruFocus

Mar 06, 2026

Demystifying Liquidia: Insights From 7 Analyst Reviews - Benzinga

Mar 06, 2026

BTIG raises Liquidia stock price target to $50 on strong launch - Investing.com

Mar 06, 2026

Liquidia stock price target raised to $55 by H.C. Wainwright - Investing.com

Mar 06, 2026

Liquidia Q4 2025 slides: revenue surges 74% but EPS miss triggers selloff - Investing.com Canada

Mar 06, 2026

Liquidia (LQDA) Q4 Profit Of US$14.6 Million Tests Longstanding Unprofitable Narrative - simplywall.st

Mar 06, 2026

Decoding Liquidia Corp (LQDA): A Strategic SWOT Insight - GuruFocus

Mar 06, 2026

Mar 05, 2026

Liquidia Q4 Earnings Call Highlights - Yahoo Finance

Mar 05, 2026

Raymond James Maintains Strong Buy on Liquidia Corporation (LQDA) March 2026 - Meyka

Mar 05, 2026